The Effect of Yoga and Laughter Yoga on Increasing the Psychological Resilience of Mothers

July 5, 2022 updated by: Tuba Koc Ozkan, Adiyaman University Research Hospital

The Effect of Yoga and Laughter Yoga on Increasing the Psychological Resilience of Mothers With Their Babies in the Neonatal Intensive Care Unit

Objective: The study will carried out in a randomized controlled trial to determine the effect of yoga and laughter yoga on increasing the psychological resilience of mothers with their babies in the Neonatal Intensive Care Unit

Method: The research will be carried out with mothers whose babies are treated in the neonatal intensive care unit. Mothers will be divided into three groups as yoga (n=20), laughter yoga (n=20) and control (n=20) by block randomization method. Research findings; Data Form will obtained by using "Introductory Characteristics Form", "Depression, Anxiety, Stress Scale (DASS-21)" and "Psychological Resilience Scale".

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Starting from the 1st week (5-7 days) after the birth, mothers will be given 10 sessions of laughter yoga (laughter group) and yoga (yoga group) twice a week for 45 minutes.DASS-21 and Resilience Scale will be administered to mothers in all groups at 1st, 3rd and 5th weeks.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Gaziantep, Turkey
        • Hasan Kalyoncu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Mothers who are older than 18 years of age,
  • whose gestational week is less than 32 weeks,
  • whose baby has been treated in the neonatal intensive care unit for at least one week,
  • who have internet access

Exclusion Criteria:

  • Mothers with a genetic disease or congenital anomaly in their baby

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Experimental: Yoga
Behavioral: Yoga
Yoga will be applied to mothers in the yoga group
Experimental: Experimental: Laughter Yoga
Behavioral: Laughter Yoga
Laughter Yoga will be applied to mothers in the yoga group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression, Anxiety, Stress Scale (DASS-21)
Time Frame: 0-3 point each item, min 0-max 21 total point each subscale
It is an assessment tool developed to evaluate the depression, anxiety and stress levels of individuals.
0-3 point each item, min 0-max 21 total point each subscale
Psychological Resilience Scale
Time Frame: min 0-max 40 point
The scale is a scale developed to determine the psychological resilience of individuals, which enables them to return to their former state after negative events.
min 0-max 40 point

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Adiyaman University Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2021

Primary Completion (Actual)

October 1, 2021

Study Completion (Actual)

October 30, 2021

Study Registration Dates

First Submitted

August 7, 2021

First Submitted That Met QC Criteria

August 7, 2021

First Posted (Actual)

August 13, 2021

Study Record Updates

Last Update Posted (Actual)

July 6, 2022

Last Update Submitted That Met QC Criteria

July 5, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/085

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Yoga

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe